Clinical Trials · NCT03541850

Stereotactic Body Radiation Therapy in Treating Patients With Localized Prostate Cancer That Have Undergone Surgery

Active Not RecruitingPhase 2Gonadorelin (Investigational)
Phase
Phase 2
Recruitment status
Active Not Recruiting
Sponsor
Jonsson Comprehensive Cancer Center
Enrollment
92
Start date
Jan 2019
Locations
2 sites, United States
Primary endpoint
Biochemical recurrence-free survival (BCRFS)
View Gonadorelin compound reference